Results 101 to 110 of about 1,348 (172)

Systemic Amyloid Light-Chain (AL) Amyloidosis Revealed by Progressive Pan-Ungual Dystrophy: A Case Report. [PDF]

Cureus
Marhraoui M, Hamada S, Haidouri S, Meziane M, Laila B.   +4 more
europepmc   +1 more source

RARE CASE OF ONYCHODYSTROPHY

Dermatology and Venerology, 2019
openaire   +1 more source

Intra-Operative Onychoscopy of Subungual Epidermoid Inclusions. [PDF]

J Dermatol
Theodosiou G, Schalock PC, Svensson Å.
europepmc   +1 more source

Dupilumab for Atopic Dermatitis with Twenty-Nail Dystrophy: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Li J, Zhang D, Dong S, Zhu L, Li X, Han Y.   +5 more
europepmc   +1 more source

Compound Heterozygous Null Variants in <i>ITGB4</i> Gene Causing Severe Phenotype of Junctional Epidermolysis Bullosa With Pyloric Atresia in Thai Newborn: Genotype-Phenotype Correlation From a Case Report and Review of the Literature. [PDF]

Int J Genomics
Klangjorhor J, Pomrop M, Thongkumkoon P, Moonsan N, Khiaomai R, Pasena A, Suksakit P, Pruksachatkun C, Tengsujaritkul M.   +8 more
europepmc   +1 more source

Limb Salvage After Deep Tissue Infection Associated with Hydroxyurea Therapy and Recommendations for a Follow-Up Protocol in Patients Treated with Hydroxyurea. [PDF]

J Clin Med
Badak É, Bodnár E, Virág L, Remenyik É, Szabó É.   +4 more
europepmc   +1 more source

Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report. [PDF]

J Int Med Res
Wang L, Lei X, Li L, Cheng Q.
europepmc   +1 more source

Efficacy of Dupilumab in Treating Trachyonychia and Other Nail Dystrophies: A Systematic Review of Case Reports. [PDF]

Cureus
Alhazmi SA, Albyali S, Alanazi R, Alhejaili BS, Alqahtani AS, Altowairqi RK, Mousa Altamimi R, Alzahrani NM, Alamoudi B, Alsweed KA, Kurdi R, Hajjaj HS, Firdous R, Samhan LM, Al-Modayfer AO.   +14 more
europepmc   +1 more source

Isolated Congenital Hyponychia and Anonychia in a Neonate: A Rare Case. [PDF]

Cureus
Tanti S, Jhajra S, Harshini V, Kumar A.
europepmc   +1 more source

Vedolizumab as a Second Line Biologic for Cronkhite Canada Syndrome and an Approach Toward Disease Monitoring. [PDF]

ACG Case Rep J
Pham JT, Feagins LA.
europepmc   +1 more source